Soligenix, Inc. (SNGX)
NASDAQ: SNGX · IEX Real-Time Price · USD
5.56
-0.51 (-8.40%)
Jul 22, 2024, 11:16 AM EDT - Market open
Soligenix Employees
As of December 31, 2023, Soligenix had 15 total employees, including 13 full-time and 2 part-time employees. The number of employees did not change compared to the previous year.
Employees
15
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$46,614
Profits / Employee
-$467,330
Market Cap
5.52M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
CareMax | 1,450 |
ReShape Lifesciences | 29 |
Hepion Pharmaceuticals | 22 |
TFF Pharmaceuticals | 19 |
Sonoma Pharmaceuticals | 10 |
Pasithea Therapeutics | 8 |
Titan Pharmaceuticals | 4 |
GT Biopharma | 2 |
SNGX News
- 7 days ago - PRISM MarketView Features Q&A with Dr. Ellen Kim: Soligenix's HyBryte™— Lighting the Way Towards Commercial Success with Promising FLASH Study Results - GlobeNewsWire
- 12 days ago - Soligenix stock rallies 400% on positive HyBryte trial results - Invezz
- 12 days ago - Crude Oil Down 1%; Soligenix Shares Surge - Benzinga
- 12 days ago - Nano-Cap Soligenix Stock Surges Over 200% On Tuesday, Here's Why - Benzinga
- 13 days ago - Expanded HyBryte™ Treatment Demonstrating Positive Outcomes in Early-Stage Cutaneous T-Cell Lymphoma - PRNewsWire
- 27 days ago - Soligenix Announces Positive Clinical Results from a Comparative Study Evaluating HyBryte™ Against Valchlor® in the Treatment of Cutaneous T-Cell Lymphoma - PRNewsWire
- 5 weeks ago - A Comparison of Vaccine Technologies to be Presented at the ASM Microbe Conference - PRNewsWire
- 6 weeks ago - Soligenix and Sharps Technology Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Accesswire